성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,775명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

Type 1 Diabetes Mellitus | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000

Type 1 Diabetes Mellitus

NCLEX Review Guide: Diabetes Mellitus in Children

Pathophysiology of Pediatric Diabetes

Type 1 Diabetes Mellitus

  • Type 1 Diabetes Mellitus (T1DM) is an autoimmune disorder characterized by destruction of pancreatic beta cells resulting in absolute insulin deficiency. In children, the onset is typically more rapid and severe than in adults, with approximately 85% of all newly diagnosed diabetes in children under 20 being Type 1.
  • The etiology involves genetic predisposition (HLA-DR3/DR4) and environmental triggers that lead to autoimmune destruction of insulin-producing cells. The autoimmune process may be present for months to years before clinical manifestations appear, with symptoms typically emerging after 80-90% of beta cells are destroyed.

Key Points

  • T1DM in children results from autoimmune destruction of pancreatic beta cells
  • Symptoms appear after 80-90% of beta cells are destroyed
  • Genetic factors (HLA-DR3/DR4) increase susceptibility

Type 2 Diabetes Mellitus

  • Type 2 Diabetes Mellitus (T2DM) in children is characterized by insulin resistance and relative insulin deficiency, rather than absolute insulin deficiency. The incidence has dramatically increased in recent decades, correlating with childhood obesity rates and now accounts for approximately 10-20% of new-onset diabetes in children and adolescents.
  • Risk factors include obesity, sedentary lifestyle, family history, ethnicity (higher in Hispanic, African American, Native American populations), and conditions like polycystic ovarian syndrome. Children with T2DM often present with less dramatic symptoms than those with T1DM and may be asymptomatic at diagnosis.

Key Points

  • T2DM in children involves insulin resistance rather than absolute deficiency
  • Obesity is the primary modifiable risk factor
  • Symptoms may be subtle or absent at diagnosis

Clinical Manifestations & Assessment

Classic Symptoms

  • The classic triad of diabetes symptoms includes polyuria (frequent urination), polydipsia (excessive thirst), and polyphagia (increased hunger). Children with T1DM typically present with these symptoms plus weight loss over a period of weeks, while children with T2DM may have more gradual onset or be asymptomatic.
  • Additional symptoms include fatigue, blurred vision, recurrent infections (especially skin and urinary tract), and delayed wound healing. Young children may present with nocturnal enuresis (bedwetting) after previously being toilet-trained, which results from the polyuria associated with hyperglycemia.

Key Points

  • Classic triad: polyuria, polydipsia, polyphagia
  • T1DM typically presents with rapid onset and weight loss
  • Secondary enuresis may be the first sign in young children

Diagnostic Criteria

  • Diagnostic criteria for diabetes in children include: fasting plasma glucose ≥126 mg/dL (7.0 mmol/L), 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test, random plasma glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. Any one of these criteria confirms the diagnosis if repeated on a subsequent day.
  • Additional laboratory findings typically include glycosuria and, in T1DM, the presence of autoantibodies (islet cell antibodies, insulin autoantibodies, GAD65, IA-2, ZnT8). C-peptide levels are typically low or undetectable in T1DM but normal or elevated in early T2DM.

Key Points

  • Fasting glucose ≥126 mg/dL or random glucose ≥200 mg/dL with symptoms
  • HbA1c ≥6.5% is diagnostic
  • Autoantibody testing helps differentiate T1DM from T2DM

Clinical Scenario

A 7-year-old boy is brought to the emergency department with a 2-week history of increased thirst, frequent urination, and a 5-pound weight loss despite increased appetite. His blood glucose is 375 mg/dL, and urine shows large amounts of glucose and moderate ketones. His parents report no family history of diabetes.

Analysis: This presentation is classic for new-onset T1DM with the triad of symptoms plus weight loss. The high blood glucose, presence of ketones, and absence of family history further support T1DM diagnosis. This child requires immediate insulin therapy and education for the family on diabetes management.

Acute Complications

Diabetic Ketoacidosis (DKA)

  • Diabetic Ketoacidosis (DKA) is characterized by the triad of hyperglycemia (blood glucose >250 mg/dL), ketosis, and metabolic acidosis (pH <7.3, bicarbonate <15 mEq/L). It results from absolute or relative insulin deficiency leading to increased gluconeogenesis, glycogenolysis, and ketogenesis.
  • Clinical manifestations include dehydration, Kussmaul respirations (deep, rapid breathing), fruity breath odor (from ketones), abdominal pain, nausea/vomiting, altered mental status, and potentially coma. DKA is more common in children with T1DM and can be the initial presentation in 25-40% of new cases.

Key Points

  • DKA triad: hyperglycemia, ketosis, and metabolic acidosis
  • Kussmaul respirations are a compensatory mechanism for acidosis
  • DKA is a medical emergency with 0.15-0.3% mortality in children

DKA Management

  1. Establish IV access and begin fluid resuscitation with isotonic saline (10-20 mL/kg in first 1-2 hours)
  2. After initial fluid bolus, continue IV fluids with added potassium once urine output is established
  3. Initiate insulin therapy with continuous IV insulin infusion at 0.05-0.1 units/kg/hour
  4. Monitor blood glucose hourly; when glucose reaches 200-250 mg/dL, add dextrose to IV fluids
  5. Monitor electrolytes, especially potassium, phosphate, and calcium every 2-4 hours
  6. Assess neurological status frequently for signs of cerebral edema
  7. Transition to subcutaneous insulin when acidosis resolves and child can eat

CLINICAL ALERT: Cerebral edema is a life-threatening complication of DKA treatment, occurring in 0.5-1% of cases with 20-25% mortality. Watch for headache, decreased level of consciousness, irregular breathing, bradycardia, hypertension, or abnormal pupillary responses. Rapid fluid administration increases risk.

Hypoglycemia

  • Hypoglycemia in diabetic children is defined as blood glucose <70 mg/dL and is typically caused by excess insulin, insufficient carbohydrate intake, or increased physical activity without appropriate insulin adjustment. Severe hypoglycemia (blood glucose <54 mg/dL) can lead to seizures, loss of consciousness, and if prolonged, brain damage.
  • Symptoms include shakiness, sweating, tachycardia, hunger, pallor, behavior changes, confusion, and drowsiness. Young children may not recognize or verbalize symptoms, making them particularly vulnerable. Nighttime hypoglycemia is especially dangerous as symptoms may not wake the child.

Key Points

  • Defined as blood glucose <70 mg/dL; severe if <54 mg/dL
  • Young children may not recognize warning symptoms
  • Treatment follows the "15-15 rule": 15g fast-acting carbohydrate, recheck in 15 minutes

Management of Pediatric Diabetes

Insulin Therapy

  • Children with T1DM require lifelong insulin replacement, typically through multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII, insulin pump). The insulin regimen usually consists of basal insulin (long-acting) plus bolus insulin (rapid-acting) for meals and corrections, with total daily dosage ranging from 0.5-1.0 units/kg/day depending on age and pubertal status.
  • Insulin types include rapid-acting (lispro, aspart, glulisine), short-acting (regular), intermediate-acting (NPH), and long-acting (glargine, detemir, degludec). Children on MDI typically receive long-acting insulin once or twice daily and rapid-acting insulin before meals based on carbohydrate counting and correction factors.

Insulin Types Comparison

Type Onset Peak Duration Examples
Rapid-acting 10-15 min 1-2 hours 3-5 hours Lispro, Aspart, Glulisine
Short-acting 30-60 min 2-4 hours 6-8 hours Regular
Intermediate-acting 1-2 hours 4-8 hours 12-16 hours NPH
Long-acting 1-2 hours Minimal peak 20-24+ hours Glargine, Detemir, Degludec

Blood Glucose Monitoring

  • Regular blood glucose monitoring is essential for diabetes management in children, with recommended frequency of 6-10 times daily for those using multiple daily injections. Continuous glucose monitoring (CGM) systems provide real-time glucose readings and trend information, allowing for more proactive management and detection of hypoglycemia.
  • Target blood glucose ranges for children with diabetes are typically 80-130 mg/dL before meals and <180 mg/dL post-meals, with HbA1c targets of <7.0% for most children, though goals should be individualized. Nighttime glucose targets are often set higher (100-150 mg/dL) to prevent nocturnal hypoglycemia.

Key Points

  • SMBG recommended 6-10 times daily; CGM provides continuous data
  • Target pre-meal glucose: 80-130 mg/dL; post-meal <180 mg/dL
  • HbA1c target <7.0% for most children

Nutritional Management

  • Nutritional management for children with diabetes focuses on carbohydrate counting, which allows for flexible meal planning and accurate insulin dosing. The insulin-to-carbohydrate ratio (I:C) typically ranges from 1:5 to 1:15 (1 unit of insulin for every 5-15g of carbohydrate) and is individualized based on age, weight, and insulin sensitivity.
  • Recommended dietary composition includes 45-55% of calories from carbohydrates, 15-20% from protein, and 25-35% from fat (primarily unsaturated). Regular meal timing is important, especially for children on fixed insulin regimens, while those on intensive insulin therapy or pumps can have more flexible meal schedules.

Carbohydrate Counting Memory Aid

Remember the "Hand Method" for estimating carbohydrates:

  • Fist = 1 cup of pasta/rice = ~30g carbs
  • Palm = 3 oz meat = 0g carbs
  • Thumb = 1 Tbsp peanut butter = ~3g carbs
  • Thumb tip = 1 tsp sugar/honey = ~5g carbs
  • Cupped hand = 1 medium fruit = ~15g carbs

Exercise Considerations

  • Physical activity is beneficial for children with diabetes but requires careful management as exercise increases glucose uptake and insulin sensitivity. For planned exercise, insulin doses may need to be reduced by 20-50% depending on intensity and duration, and additional carbohydrates may be needed (typically 15-30g per hour of moderate activity).
  • Blood glucose should be checked before, during (for prolonged activity), and after exercise. Exercise should be avoided if blood glucose is >250 mg/dL with ketones or <90 mg/dL. The risk of hypoglycemia is increased for up to 24 hours after significant exercise due to increased insulin sensitivity and glycogen replenishment.

Key Points

  • Reduce insulin by 20-50% for planned exercise
  • Consume 15-30g carbs per hour of moderate activity
  • Risk of delayed hypoglycemia up to 24 hours post-exercise

Long-term Complications & Monitoring

Microvascular Complications

  • Diabetic retinopathy is damage to the retinal blood vessels caused by chronic hyperglycemia. Screening should begin at age 11 with 2-5 years of diabetes duration or at puberty onset in those with diabetes for 3-5 years. Annual comprehensive eye examinations are recommended thereafter.
  • Diabetic nephropathy involves kidney damage characterized by albuminuria and declining glomerular filtration rate. Screening should begin at age 10 with 5 years of diabetes duration via annual urine albumin-to-creatinine ratio testing. Early detection and treatment with ACE inhibitors can slow progression.
  • Diabetic neuropathy affects peripheral and autonomic nerves. Screening should begin at age 10 with 5 years of diabetes duration through annual comprehensive foot examinations and assessment of symptoms like numbness, tingling, or pain.

Key Points

  • Retinopathy screening begins at age 11 or at puberty with 2-5 years duration
  • Nephropathy screening begins at age 10 with 5 years duration
  • Tight glycemic control reduces risk of all microvascular complications

Psychosocial Considerations

  • Children with diabetes face unique psychosocial challenges including disease burden, fear of hypoglycemia, body image concerns, and peer relationships. Diabetes distress and depression are more common in youth with diabetes, with approximately 20% experiencing clinically significant depression compared to 7% of peers without diabetes.
  • Adolescence presents particular challenges due to hormonal changes affecting insulin sensitivity, desire for independence, risk-taking behaviors, and competing priorities. Non-adherence to treatment regimens is common during this period, with studies showing that only 21% of adolescents meet all treatment goals.

Key Points

  • Screen for depression and diabetes distress at diagnosis and annually
  • Adolescents have unique challenges requiring targeted support
  • Family involvement improves adherence and outcomes

Transition to Adult Care

  • Transition planning should begin in early adolescence (12-14 years) with a structured process to prepare for transfer to adult care, typically between ages 18-21. The transition process should include gradual shifting of self-management responsibilities, development of self-advocacy skills, and education about adult healthcare systems.
  • Key transition readiness skills include independent diabetes management, scheduling appointments, communicating with providers, refilling prescriptions, and understanding insurance. Studies show that structured transition programs reduce gaps in care and emergency department visits during the transition period.

Key Points

  • Begin transition planning at age 12-14 years
  • Assess transition readiness skills regularly
  • Structured transition programs improve outcomes

Commonly Confused Points

Type 1 vs. Type 2 Diabetes in Children

Feature Type 1 Diabetes Type 2 Diabetes
Pathophysiology Autoimmune destruction of beta cells Insulin resistance with relative insulin deficiency
Onset Typically rapid (days to weeks) Usually gradual (months to years)
Body habitus Often thin or normal weight Usually overweight/obese (>85% of cases)
Age at onset Any age, peaks at 5-7 and 11-13 years Usually pubertal or post-pubertal
Family history 10-15% have first-degree relative with T1DM 75-90% have first-degree relative with T2DM
Autoantibodies Present in 85-95% of cases Typically absent
C-peptide Low or undetectable Normal or elevated initially
DKA at diagnosis Common (25-40%) Less common (5-10%)
Treatment Always requires insulin May start with lifestyle/metformin; may need insulin

DKA vs. Hyperosmolar Hyperglycemic State (HHS)

Feature Diabetic Ketoacidosis (DKA) Hyperosmolar Hyperglycemic State (HHS)
Blood glucose >250 mg/dL (typically 300-800 mg/dL) >600 mg/dL (often >1000 mg/dL)
Ketones Moderate to large Absent or minimal
Acidosis Present (pH <7.3, bicarbonate <15 mEq/L) Absent or mild
Osmolality Variable, often elevated Markedly elevated (>320 mOsm/kg)
Dehydration 5-10% body weight 10-15% body weight
Mental status Variable, from alert to comatose Often significantly altered
Type of diabetes More common in T1DM More common in T2DM
Mortality 0.15-0.3% in children 10-20% (rare in children)

Hypoglycemia vs. Insulin Shock

  • Though often used interchangeably, hypoglycemia refers to low blood glucose (<70 mg/dL) with mild to moderate symptoms, while insulin shock refers specifically to severe hypoglycemia with altered mental status, loss of consciousness, or seizures requiring assistance from others for treatment.
  • The treatment for mild to moderate hypoglycemia follows the "15-15 rule" (15g fast-acting carbohydrate, recheck in 15 minutes), while insulin shock requires glucagon administration (0.5mg for children <25kg, 1mg for ≥25kg) via injection or nasal spray, followed by emergency medical attention.

CLINICAL ALERT: Never give oral treatment to an unconscious child with hypoglycemia due to aspiration risk. Use glucagon injection or nasal spray and position in recovery position while awaiting emergency services.

Study Tips & Memory Aids

Memorizing Signs of Hypoglycemia

The "Rule of 15s" for Hypoglycemia

Use this mnemonic to remember hypoglycemia signs and treatment:

  • F - Feeling shaky
  • I - Irritability/mood changes
  • F - Fatigue/weakness
  • T - Tachycardia
  • E - Excess sweating
  • E - Empty feeling/hunger
  • N - Numbness/tingling

Treatment: 15g carbs, wait 15 minutes, recheck. If still <70 mg/dL, repeat 15g carbs.

Remembering DKA Assessment

"KUSSMAUL" for DKA Assessment

  • K - Ketones (breath, urine, blood)
  • U - Urination (polyuria)
  • S - Sunken eyes (dehydration)
  • S - Stupor/altered mental status
  • M - Metabolic acidosis
  • A - Air hunger (deep respirations)
  • U - Unquenchable thirst
  • L - Loss of weight

Insulin Action Memory Aid

"RAPID" for Insulin Action Times

  • Rapid-acting: Really quick (onset 10-15 min, peaks 1-2 hours, duration 3-5 hours)
  • Aspart, ApiRapid: Acts like rapid-acting
  • Prandial (Regular): Peaks later (onset 30-60 min, peaks 2-4 hours, duration 6-8 hours)
  • Intermediate (NPH): In the middle (onset 1-2 hours, peaks 4-8 hours, duration 12-16 hours)
  • Detemir, Degludec, Degludec: Daily long-acting (onset 1-2 hours, minimal peak, duration 20-24+ hours)

Common Pitfalls in NCLEX Questions

  • When answering NCLEX questions about pediatric diabetes, avoid the common pitfall of applying adult diabetes concepts directly to children. Children have different insulin requirements (often higher per kg), more pronounced hormonal effects during growth and puberty, and unique developmental and psychosocial needs that affect management.
  • Another common error is confusing the presentation of new-onset T1DM with other conditions. Remember that new-onset diabetes in children can mimic gastroenteritis (due to vomiting from DKA), appendicitis (due to abdominal pain from DKA), or urinary tract infection (due to polyuria and sometimes enuresis).

Key NCLEX Testing Points

  • For DKA questions, focus on fluid resuscitation first, then insulin therapy
  • For hypoglycemia questions, treatment priority depends on consciousness level
  • For diabetes management questions, remember developmental considerations

Quick Check: Test Your Knowledge

  1. What are the classic symptoms of diabetes in children?
  2. What is the diagnostic criterion for diabetes based on fasting plasma glucose?
  3. What are the three components of DKA?
  4. What is the recommended initial fluid resuscitation for a child with DKA?
  5. What is the definition of hypoglycemia in children with diabetes?
  6. What is the "15-15 rule" for treating mild hypoglycemia?
  7. What is the main difference between Type 1 and Type 2 diabetes in children?
  8. When should screening for diabetic retinopathy begin?
  9. What is the target HbA1c for most children with diabetes?
  10. What is a serious complication of DKA treatment in children?

Remember that understanding pediatric diabetes management is crucial for providing safe, effective care. Children with diabetes have unique physiological, developmental, and psychosocial needs that require specialized nursing knowledge. Your expertise in this area will directly impact a child's quality of life and long-term health outcomes. Stay confident in your knowledge and approach each patient with compassion, recognizing that you're helping them build lifelong health management skills.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.